Background The evidence on the economic burden of cardiovascular disease (CVD) in low-
and middle-income countries (LMICs) remains scarce. We conducted a comprehensive …

Globally, more than 5 million people die annually from lack of access to critical treatments for
kidney disease—by 2040, chronic kidney disease is projected to be the fifth leading cause of …

There has been a rapid escalation of type 2 diabetes (T2D) in developing countries, with
varied prevalence according to rural vs urban habitat and degree of urbanization. Some …

Surgery is essential for global cancer care in all resource settings. Of the 15· 2 million new
cases of cancer in 2015, over 80% of cases will need surgery, some several times. By 2030 …

Diabetes mellitus (DM) is a public health problem in developing as well as developed
nations. DM leads to many complications that are associated with higher morbidity and …

Background Expanding public health insurance seeks to attain several desirable objectives,
including increasing access to healthcare services, reducing the risk of catastrophic …

Demographic and epidemiological changes are shifting the disease burden from
communicable to noncommunicable diseases in lower-income countries. Within a …

There is an alarmingly high growth in breast and cervical cancers in low-and middle-income
countries. Due to late presentation to doctors, there is a lower cure rate. The screening …

Background The chronic nature of noncommunicable diseases (NCD) and costs associated
with long-term care can result in catastrophic health expenditure for the patient and their …

The pandemic of chronic non-communicable diseases (NCDs) poses substantial challenges
to the health financing sustainability in high-income and low/middle income countries …